Loading university
Stephen G. Sligar — The lab led by Stephen G. Sligar at the University of Illinois focuses on understanding how membrane proteins work within lipid bilayers, which are essential for cell function. By using a special technology called Nanodiscs, which create small, stable environments that mimic natural cellular conditions, the lab explores how these proteins affect processes like hormone production and drug metabolism. This research aims to reveal the intricate mechanisms behind cell signaling and communication, key areas important for health and disease.
Huimin Zhao — Dr. Huimin Zhao's lab focuses on discovering new antibiotics from natural products, particularly a special group called ribosomally synthesized and post-translationally modified peptides (RiPPs). By using advanced technologies like artificial intelligence and synthetic biology, they aim to enhance the production of these promising compounds and improve the ability to predict their structures. The research ultimately seeks to address the growing problem of antibiotic resistance by developing new antibacterial agents.
Jing Yang — Dr. Jing Yang's lab at the University of Illinois is focused on understanding the critical processes that occur during the transition from oocyte to embryo, specifically in vertebrates like frogs and zebrafish. They investigate how the cellular components and maternal RNA are reorganized to support successful reproduction. Their research aims to uncover new mechanisms that could explain unexplained infertility in humans, enhancing reproductive health.
James A. Imlay — Dr. James A. Imlay's lab studies how bacteria cope with the challenges posed by oxygen and reactive oxygen species. Bacteria have evolved various defenses to counteract the damaging effects of oxidative stress that can harm their enzymes and DNA. By investigating how different bacteria produce and manage reactive oxygen species, the lab aims to enhance our understanding of bacterial survival and adaptation in oxygen-rich environments, potentially leading to better antibiotic development.
Jodi A. Flaws — Dr. Jodi A. Flaws' lab at the University of Illinois focuses on the impact of environmental chemicals, specifically phthalates and endocrine disrupting chemicals (EDCs), on female reproductive health. The lab investigates how these chemicals contribute to early reproductive aging, which can lead to issues like infertility and other health complications in midlife women. By using advanced techniques to understand the mechanisms behind EDC-induced ovarian damage, the lab aims to identify potential treatments and preventive strategies.
Andrew Michael Smith — Dr. Andrew Smith's lab focuses on developing innovative delivery systems for cancer therapies and obesity management. They are particularly interested in using nanocarriers for targeted treatment of metastatic breast cancer and advancing blood-based diagnostics for prostate cancer. Their work aims to improve health outcomes through personalized medicine by harnessing the body’s immune responses and minimizing side effects.
Paul Hergenrother — Paul Hergenrother's lab focuses on developing new antibiotics to combat drug-resistant Gram-negative bacteria and on creating targeted cancer therapies. By understanding how drugs enter and exit bacterial cells, they aim to invent antibiotics that can effectively treat infections caused by difficult pathogens like E. coli. The lab also works on personalized cancer treatment by designing drugs that target specific abnormalities in cancer cells, advancing multiple promising drug candidates to clinical trials.
Nicholas C. Wu — Dr. Nicholas C. Wu's lab focuses on understanding how human antibodies recognize and bind to various antigens, which is essential for developing effective vaccines and therapies. They employ a high-throughput method to study the interactions between antibodies and influenza A virus proteins, aiming to predict antibody epitope specificity based on their amino acid sequences. This research could enhance our knowledge of the human immune system and inform better approaches to fight against pathogens.
Satish K Nair — Dr. Satish K Nair's lab at the University of Illinois studies natural products called RiPPs, which are created from simple peptide sequences and have various medical applications. The lab focuses on understanding how certain enzymes transform these peptides into active compounds that can fight diseases like cancer and infections. By investigating the structure and function of these enzymes, the research aims to develop new and improved therapeutic drugs.